Latest filing published 15 Jul 2026 for Nuvalent, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Darlene Noci discloses dealings in Nuvalent, Inc. to SEC (Form 4). In total, 61 filings cover trades dated from 15 February 2022 to 15 July 2026.
Sales make up the whole of the open-market record (7 sales, €3.5M). Other entries cover 3 share grants and 48 option exercises. In 2026 alone, the filings show no purchases and 7 sales.
On 15 July 2026 came the latest disclosure, a share grant in Nuvalent, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 61 declarations